LFST LifeStance Health Group, Inc.
P/E
96.615395
Forward P/E
29.158445
Price/Sales
3.0127673
Beta
1.239
Div Yield
0.0%
Market Cap
--
Company Analysis
Latest News
LifeStance Health beats third quarter 2026 estimates and raises guidance as clinician base hits 8,863
LifeStance reported a significant beat on both the top and bottom lines for the third quarter of 2026, driven by robust clinician hiring and improved...
LifeStance Health Group, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
LifeStance Health is expected to report consensus revenue of $431.59 million and EPS of $0.04, with the current stock price of $13.39 trading slightly below...